{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:12:22Z","timestamp":1772788342296,"version":"3.50.1"},"reference-count":47,"publisher":"Informa UK Limited","issue":"14","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Celltrion Inc."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.2217\/imt-2022-0290","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T05:13:56Z","timestamp":1692249236000},"page":"1143-1155","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Safety and Effectiveness of Intravenous Ct-P13 in Inflammatory Arthritis: Post-Marketing Surveillance Study in Thailand"],"prefix":"10.1080","volume":"15","author":[{"given":"Ajanee","family":"Mahakkanukrauh","sequence":"first","affiliation":[{"name":"Khon Kaen University Hospital, Nai Mueang, Mueang Khon Kaen","place":["Khon Kaen, Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumapa","family":"Chaiamnuay","sequence":"additional","affiliation":[{"name":"Phramongkutklao Hospital, Ratchathewi","place":["Bangkok, Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajchara","family":"Koolvisoot","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, Faculty of Medicine, Siriraj Hospital","place":["Bangkoknoi, Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tassanee","family":"Kitamnuayphong","sequence":"additional","affiliation":[{"name":"Rajavithi Hospital, Thung Phaya Thai, Ratchathewi","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siriporn","family":"Manavathongchai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rheumatology Division, Faculty of Medicine Vajira Hospital, Navamindradhiraj University","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manathip","family":"Osiri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, Faculty of Medicine, Chulalongkorn University","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Worawit","family":"Louthrenoo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Chiang Mai University","place":["Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parichat","family":"Uea-areewongsa","sequence":"additional","affiliation":[{"name":"Allergy & Rheumatology Unit, Division of Medicine, Faculty of Medicine, Prince of Songkla University","place":["Hat Yai, Thailand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keumyoung","family":"Ahn","sequence":"additional","affiliation":[{"name":"Celltrion, Inc","place":["Incheon, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahyun","family":"Jung","sequence":"additional","affiliation":[{"name":"Celltrion, Inc","place":["Incheon, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minkyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Celltrion, Inc","place":["Incheon, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seulgi","family":"Lee","sequence":"additional","affiliation":[{"name":"Celltrion, Inc","place":["Incheon, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Kim","sequence":"additional","affiliation":[{"name":"Celltrion, Inc","place":["Incheon, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunghyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Celltrion, Inc","place":["Incheon, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1478-6354-13-S1-S2"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S55928"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463200902200301"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41042"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41752"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13513"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210770"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13510"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217159"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40726"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2020-0086"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2020.1868078"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1812575"},{"key":"e_1_3_7_17_1","unstructured":"European Medicines Agency . Remsima: summary of product characteristics (2022). www.ema.europa.eu\/en\/documents\/product-information\/remsima-epar-product-information_en.pdf (Accessed 22August2022)."},{"key":"e_1_3_7_18_1","unstructured":"European Medicines Agency . Inflectra: summary of product characteristics (2022). www.ema.europa.eu\/en\/documents\/product-information\/inflectra-epar-product-information_en.pdf (Accessed 28September2022)."},{"key":"e_1_3_7_19_1","unstructured":"US Food and Drug Administration . Inflectra: prescribing information (2021). www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/125544s018lbl.pdf (Accessed 28September2022)."},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203091"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203090"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2020.1682553"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-020-00421-2"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01834-3"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2016.03.006"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.10.015"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15242"},{"key":"e_1_3_7_28_1","article-title":"Certificate of drug registration for modern drug type: remsima (CT-P13)","author":"Thailand Food and Drug Administration","year":"2015","unstructured":"Thailand Food and Drug Administration . Certificate of drug registration for modern drug type: remsima (CT-P13). THAI.FDA.A4 0884165 (2015).","journal-title":"THAI.FDA.A4 0884165"},{"key":"e_1_3_7_29_1","unstructured":"MIMS . Remsima: prescribing information (2022). www.mims.com\/thailand\/drug\/info\/remsima\/dosage (Accessed 31August2022)."},{"key":"e_1_3_7_30_1","unstructured":"Celltrion Healthcare (Thailand) Co. Ltd . Remsima\u00ae (infliximab) 100 mg powder for concentrate for solution for infusion (package insert) (2022)."},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2020.1803889"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13130"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972"},{"key":"e_1_3_7_36_1","unstructured":"Thai Clinical Trials Registry . Post-marketing surveillance of REMSIMA 100 mg. (Infliximab)(monoclonal antibody recombinant) to evaluate its safety and efficacy in Thailand (TCTR20170817005) (2018). www.thaiclinicaltrials.org\/show\/TCTR20170817005 (Accessed 28September2022)."},{"key":"e_1_3_7_37_1","unstructured":"Thai Rheumatism Association . Practice guidelines for use of biological agents in the treatment of rheumatic disorders (2009). http:\/\/thairheumatologyorg\/download\/guideline_biolo_gic_therapypdf"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roab068"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-55512-8.00020-X"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa043"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg354"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00393-y"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/z0va6o"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh297"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204920"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206651"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.3897\/folmed.62.e47714"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq117"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2022-0290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:38:11Z","timestamp":1772779091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2022-0290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":47,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.2217\/imt-2022-0290"],"URL":"https:\/\/doi.org\/10.2217\/imt-2022-0290","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}